Clinical application of a novel next generation sequencing assay for CYP21A2 gene in 310 cases of 21- hydroxylase congenital adrenal hyperplasia from India.

MLA

Gangodkar, Priyanka, et al. “Clinical Application of a Novel next Generation Sequencing Assay for CYP21A2 Gene in 310 Cases of 21- Hydroxylase Congenital Adrenal Hyperplasia from India.” Endocrine, vol. 71, no. 1, Jan. 2021, pp. 189–98. EBSCOhost, https://doi.org/10.1007/s12020-020-02494-z.

APA

Gangodkar, P., Khadilkar, V., Raghupathy, P., Kumar, R., Dayal, A. A., Dayal, D., Ayyavoo, A., Godbole, T., Jahagirdar, R., Bhat, K., Gupta, N., Kamalanathan, S., Jagadeesh, S., Ranade, S., Lohiya, N., Oke, R. L., Ganesan, K., Khatod, K., Agarwal, M., … Khadilkar, A. (2021). Clinical application of a novel next generation sequencing assay for CYP21A2 gene in 310 cases of 21- hydroxylase congenital adrenal hyperplasia from India. Endocrine, 71(1), 189–198. https://doi.org/10.1007/s12020-020-02494-z

Chicago

Gangodkar, Priyanka, Vaman Khadilkar, P Raghupathy, Rakesh Kumar, Archana Arya Dayal, Devi Dayal, Ahila Ayyavoo, et al. 2021. “Clinical Application of a Novel next Generation Sequencing Assay for CYP21A2 Gene in 310 Cases of 21- Hydroxylase Congenital Adrenal Hyperplasia from India.” Endocrine 71 (1): 189–98. doi:10.1007/s12020-020-02494-z.